Skip to main content
Top
Published in: Medical Oncology 3/2007

01-09-2007 | Original Article

Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer

Authors: Cem H. Misirlioglu, Taciser Demirkasimoglu, Bulent Kucukplakci, Ergun Sanri, Kadri Altundag

Published in: Medical Oncology | Issue 3/2007

Login to get access
Metadata
Title
Pentoxifylline and alpha-tocopherol in prevention of radiation-induced lung toxicity in patients with lung cancer
Authors
Cem H. Misirlioglu
Taciser Demirkasimoglu
Bulent Kucukplakci
Ergun Sanri
Kadri Altundag
Publication date
01-09-2007
Publisher
Humana Press Inc
Published in
Medical Oncology / Issue 3/2007
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-007-0006-z

Other articles of this Issue 3/2007

Medical Oncology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine